Cargando…

Proteomic Profiling of IgG1 Producing CHO Cells Using LC/LC-SPS-MS(3): The Effects of Bioprocessing Conditions on Productivity and Product Quality

The biopharmaceutical market is dominated by monoclonal antibodies, the majority of which are produced in Chinese hamster ovary (CHO) cell lines. Intense cell engineering, in combination with optimization of various process parameters results in increasing product titers. To enable further improveme...

Descripción completa

Detalles Bibliográficos
Autores principales: Strasser, Lisa, Farrell, Amy, Ho, Jenny T. C., Scheffler, Kai, Cook, Ken, Pankert, Patrick, Mowlds, Peter, Viner, Rosa, Karger, Barry L., Bones, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062983/
https://www.ncbi.nlm.nih.gov/pubmed/33898396
http://dx.doi.org/10.3389/fbioe.2021.569045
_version_ 1783681879259480064
author Strasser, Lisa
Farrell, Amy
Ho, Jenny T. C.
Scheffler, Kai
Cook, Ken
Pankert, Patrick
Mowlds, Peter
Viner, Rosa
Karger, Barry L.
Bones, Jonathan
author_facet Strasser, Lisa
Farrell, Amy
Ho, Jenny T. C.
Scheffler, Kai
Cook, Ken
Pankert, Patrick
Mowlds, Peter
Viner, Rosa
Karger, Barry L.
Bones, Jonathan
author_sort Strasser, Lisa
collection PubMed
description The biopharmaceutical market is dominated by monoclonal antibodies, the majority of which are produced in Chinese hamster ovary (CHO) cell lines. Intense cell engineering, in combination with optimization of various process parameters results in increasing product titers. To enable further improvements in manufacturing processes, detailed information about how certain parameters affect cellular mechanisms in the production cells, and thereby also the expressed drug substance, is required. Therefore, in this study the effects of commonly applied changes in bioprocessing parameters on an anti-IL8 IgG1 producing CHO DP-12 cell line were investigated on the level of host cell proteome expression combined with product quality assessment of the expressed IgG1 monoclonal antibody. Applying shifts in temperature, pH and dissolved oxygen concentration, respectively, resulted in altered productivity and product quality. Furthermore, analysis of the cells using two-dimensional liquid chromatography-mass spectrometry employing tandem mass tag based isotopic quantitation and synchronous precursor selection-MS(3) detection revealed substantial changes in the protein expression profiles of CHO cells. Pathway analysis indicated that applied bioprocessing conditions resulted in differential activation of oxidative phosphorylation. Additionally, activation of ERK5 and TNFR1 signaling suggested an affected cell cycle. Moreover, in-depth product characterization by means of charge variant analysis, peptide mapping, as well as structural and functional analysis, revealed posttranslational and structural changes in the expressed drug substance. Taken together, the present study allows the conclusion that, in anti-IL8 IgG1 producing CHO DP-12 cells, an improved energy metabolism achieved by lowering the cell culture pH is favorable when aiming towards high antibody production rates while maintaining product quality.
format Online
Article
Text
id pubmed-8062983
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80629832021-04-24 Proteomic Profiling of IgG1 Producing CHO Cells Using LC/LC-SPS-MS(3): The Effects of Bioprocessing Conditions on Productivity and Product Quality Strasser, Lisa Farrell, Amy Ho, Jenny T. C. Scheffler, Kai Cook, Ken Pankert, Patrick Mowlds, Peter Viner, Rosa Karger, Barry L. Bones, Jonathan Front Bioeng Biotechnol Bioengineering and Biotechnology The biopharmaceutical market is dominated by monoclonal antibodies, the majority of which are produced in Chinese hamster ovary (CHO) cell lines. Intense cell engineering, in combination with optimization of various process parameters results in increasing product titers. To enable further improvements in manufacturing processes, detailed information about how certain parameters affect cellular mechanisms in the production cells, and thereby also the expressed drug substance, is required. Therefore, in this study the effects of commonly applied changes in bioprocessing parameters on an anti-IL8 IgG1 producing CHO DP-12 cell line were investigated on the level of host cell proteome expression combined with product quality assessment of the expressed IgG1 monoclonal antibody. Applying shifts in temperature, pH and dissolved oxygen concentration, respectively, resulted in altered productivity and product quality. Furthermore, analysis of the cells using two-dimensional liquid chromatography-mass spectrometry employing tandem mass tag based isotopic quantitation and synchronous precursor selection-MS(3) detection revealed substantial changes in the protein expression profiles of CHO cells. Pathway analysis indicated that applied bioprocessing conditions resulted in differential activation of oxidative phosphorylation. Additionally, activation of ERK5 and TNFR1 signaling suggested an affected cell cycle. Moreover, in-depth product characterization by means of charge variant analysis, peptide mapping, as well as structural and functional analysis, revealed posttranslational and structural changes in the expressed drug substance. Taken together, the present study allows the conclusion that, in anti-IL8 IgG1 producing CHO DP-12 cells, an improved energy metabolism achieved by lowering the cell culture pH is favorable when aiming towards high antibody production rates while maintaining product quality. Frontiers Media S.A. 2021-04-09 /pmc/articles/PMC8062983/ /pubmed/33898396 http://dx.doi.org/10.3389/fbioe.2021.569045 Text en Copyright © 2021 Strasser, Farrell, Ho, Scheffler, Cook, Pankert, Mowlds, Viner, Karger and Bones. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Strasser, Lisa
Farrell, Amy
Ho, Jenny T. C.
Scheffler, Kai
Cook, Ken
Pankert, Patrick
Mowlds, Peter
Viner, Rosa
Karger, Barry L.
Bones, Jonathan
Proteomic Profiling of IgG1 Producing CHO Cells Using LC/LC-SPS-MS(3): The Effects of Bioprocessing Conditions on Productivity and Product Quality
title Proteomic Profiling of IgG1 Producing CHO Cells Using LC/LC-SPS-MS(3): The Effects of Bioprocessing Conditions on Productivity and Product Quality
title_full Proteomic Profiling of IgG1 Producing CHO Cells Using LC/LC-SPS-MS(3): The Effects of Bioprocessing Conditions on Productivity and Product Quality
title_fullStr Proteomic Profiling of IgG1 Producing CHO Cells Using LC/LC-SPS-MS(3): The Effects of Bioprocessing Conditions on Productivity and Product Quality
title_full_unstemmed Proteomic Profiling of IgG1 Producing CHO Cells Using LC/LC-SPS-MS(3): The Effects of Bioprocessing Conditions on Productivity and Product Quality
title_short Proteomic Profiling of IgG1 Producing CHO Cells Using LC/LC-SPS-MS(3): The Effects of Bioprocessing Conditions on Productivity and Product Quality
title_sort proteomic profiling of igg1 producing cho cells using lc/lc-sps-ms(3): the effects of bioprocessing conditions on productivity and product quality
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062983/
https://www.ncbi.nlm.nih.gov/pubmed/33898396
http://dx.doi.org/10.3389/fbioe.2021.569045
work_keys_str_mv AT strasserlisa proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT farrellamy proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT hojennytc proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT schefflerkai proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT cookken proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT pankertpatrick proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT mowldspeter proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT vinerrosa proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT kargerbarryl proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality
AT bonesjonathan proteomicprofilingofigg1producingchocellsusinglclcspsms3theeffectsofbioprocessingconditionsonproductivityandproductquality